ELTX - Elicio Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

45.07M

Cash

11.85M

Avg Qtr Burn

-9.169M

Short % of Float

1.34%

Insider Ownership

28.28%

Institutional Own.

3.87%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ELI-002 2P Details Solid tumor/s, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ELI-002 7P Details Cancer, Pancreatic cancer	Phase 1a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.